Risk Evaluation and Mitigation Strategies for some Rx drugs

You'll hear lots more about "REMS" as FDA phases in their new Risk Evaluation and Mitigation Strategies for some Rx drugs....

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote